Skip to main content
Log in

Patient Preferences for Managing Insomnia: A Discrete Choice Experiment

  • Original Research Article
  • Published:
The Patient - Patient-Centered Outcomes Research Aims and scope Submit manuscript

Abstract

Background

Despite the rapid development of effective treatments, both pharmacological and non-pharmacological, insomnia management remains suboptimal at the practice interface. Patient preferences play a critical role in influencing treatment outcomes. However, there is currently a mismatch between patient preferences and clinician recommendations, partly perpetuated by a limited understanding of the patients’ decision-making process.

Objectives

The aim of our study was to empirically quantify patient preferences for treatment attributes common to both pharmacological and non-pharmacological insomnia treatments.

Method

An efficient dual-response discrete choice experiment was conducted to evaluate patient treatment preferences for managing insomnia. The sample included 205 patients with self-reported insomnia and an Insomnia Severity Index ≥ 14. Participants were presented with two unlabelled hypothetical scenarios with an opt-out option across 12 choice sets. Data were analyzed using a mixed multinomial logit model to investigate the influence of five attributes (i.e. time, onset of action, maintainability of improved sleep, length of treatment, and monthly cost) on treatment preferences.

Results

Treatments were preferentially viewed if they conferred long-term sleep benefits (p < 0.05); had an ongoing, as opposed to a predefined, duration of treatment course (p < 0.05); required some, as opposed to no, additional time commitment (p < 0.05); and had lower monthly out-of-pocket treatment costs (p < 0.001). However, treatment onset of action had no influence on preference. Age, help-seeking status, concession card status and fatigue severity significantly influenced treatment preference.

Conclusion

Participants’ prioritization of investing time in treatment and valuing the maintainability of therapeutic gains suggests a stronger inclination towards non-pharmacological treatment, defying current assumptions that patients prefer ‘quick-fixes’ for managing insomnia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Notes

  1. Benzodiazepine receptor agonists, e.g. temazepam and zolpidem.

  2. Cognitive behavioural treatment for insomnia (CBT-I).

  3. The Woolcock Institute of Medical Research (WIMR), Sydney, Australia, and Brain and Mind Centre (formerly Brain and Mind Research Institute), Sydney, Australia.

  4. General Practice Clinics and Community Pharmacy.

  5. Sleep Disorders Australia is a group that aims to provide information and support to individuals with sleep disorders and their families (https://www.sleepoz.org.au/)

  6. The attribute levels for cost (i.e. $15, $30, $60, $120 and $240) were informed by an estimation of the cost of a private prescription for zolpidem at $19, the recommended fee schedule of $181 for a 31- to 45-min consultation with a psychologist in 2015. We also accounted for patients’ willingness to pay $40 into the cost attribute levels.

  7. DASS-21 reported as three separate subscales for Depression, Anxiety and Stress symptoms.

References

  1. Ohayon M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111.

    Article  PubMed  Google Scholar 

  2. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–33.

    Article  PubMed  Google Scholar 

  3. Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7(2):123–30.

    Article  CAS  PubMed  Google Scholar 

  4. Dyas JV, Apekey TA, Tilling M, Orner R, Middleton H, Siriwardena AN. Patients’ and clinicians’ experiences of consultations in primary care for sleep problems and insomnia: a focus group study. Br J Gen Pract. 2010;60(574):e180–200.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sirdifield C, Chipchase SY, Owen S, Siriwardena AN. A systematic review and meta-synthesis of patients’ experiences and perceptions of seeking and using benzodiazepines and Z-drugs: towards safer prescribing. Patient. 2017;10(1):1–15.

    Article  PubMed  Google Scholar 

  6. Kripke DF. Mortality risk of hypnotics: strengths and limits of evidence. Drug Saf. 2016;39(2):93–107.

    Article  PubMed  Google Scholar 

  7. Panneman MJM, Goettsch WG, Kramarz P, Herings RMC. The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a pharmo study. Drugs Aging. 2003;20(11):833–9.

    Article  PubMed  Google Scholar 

  8. Pollmann AS, Murphy AL, Bergman JC, Gardner DM. Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol. 2015;16:19.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mitchell M, Gehrman P, Perlis M, Umscheid C. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R. Trends in prescribing of sedative-hypnotic medications in the USA: 1993–2010. Pharmacoepidemiol Drug Saf. 2016;25(6):637–45.

    Article  CAS  PubMed  Google Scholar 

  11. Vincent N, Lionberg C. Treatment preference and patient satisfaction in chronic insomnia. Sleep. 2001;24(4):411–7.

    Article  CAS  PubMed  Google Scholar 

  12. Bluestein D, Healey AC, Rutledge CM. Acceptability of behavioral treatments for insomnia. J Am Board Fam Med. 2011;24(3):272–80.

    Article  PubMed  Google Scholar 

  13. Légaré F, Witteman HO. Shared decision making: examining key elements and barriers to adoption into routine clinical practice. Health Aff. 2013;32(2):276–84.

    Article  Google Scholar 

  14. Morin CM, Gaulier B, Barry T, Kowatch RA. Patients’ acceptance of psychological and pharmacological therapies for insomnia. Sleep. 1992;15(4):302–5.

    Article  CAS  PubMed  Google Scholar 

  15. Bouchard S, Bastien C, Morin CM. Self-efficacy and adherence to cognitive-behavioral treatment of insomnia. Behav Sleep Med. 2003;1(4):187–99.

    Article  PubMed  Google Scholar 

  16. Vincent N, Lewycky S, Finnegan H. Barriers to engagement in sleep restriction and stimulus control in chronic insomnia. J Consult Clin Psychol. 2008;76(5):820–8.

    Article  PubMed  Google Scholar 

  17. Mulley AG, Trimble C, Elwyn G. Stop the silent misdiagnosis: patients’ preferences matter. BMJ. 2012;345:e6572–8.

    Article  PubMed  Google Scholar 

  18. Horne R. Patients’ beliefs about treatment: The hidden determinant of treatment outcome? J Psychosom Res. 1999;47(6):491–5.

    Article  CAS  PubMed  Google Scholar 

  19. Johnson FR, Lancsar E, Marshall D, Kilambi V, Mühlbacher A, Regier DA, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3–13.

    Article  Google Scholar 

  20. Cheung JMY, Bartlett DJ, Armour CL, Laba T-L, Saini B. To drug or not to drug: a qualitative study of patients’ decision-making processes for managing insomnia. Behav Sleep Med. 2018;16(1):1–26.

    Article  PubMed  Google Scholar 

  21. Bliemer MCJ, Rose JM, Hess S. Approximation of bayesian efficiency in experimental choice designs. J Choice Model. 2008;1(1):98–126.

    Article  Google Scholar 

  22. Rose JM, Bliemer MCJ. Constructing efficient stated choice experimental designs. Transp Rev. 2009;29(5):587–617.

    Article  Google Scholar 

  23. Laba T-L, Brien J-A, Fransen M, Jan S. Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS). BMC Musculoskelet Disord. 2013;14(1):160.

    Article  PubMed  PubMed Central  Google Scholar 

  24. de Bekker-Grob EW, Bliemer MCJ, Donkers B, Essink-Bot ML, Korfage IJ, Roobol MJ, et al. Patients’ and urologists’ preferences for prostate cancer treatment: a discrete choice experiment. Br J Cancer. 2013;109(3):633–40.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Pearmain D. Stated preference techniques: a guide to practice. London: Steer Davies Gleave; 1991.

    Google Scholar 

  26. Veldwijk J, Lambooij MS, de Bekker-Grob EW, Smit HA, de Wit GA. The effect of including an opt-out option in discrete choice experiments. PLoS One. 2014;9(11):e111805.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Brazell JD, Diener CG, Karniouchina E, Moore WL, Séverin V, Uldry P-F. The no-choice option and dual response choice designs. Mark Lett. 2006;17(4):255–68.

    Article  Google Scholar 

  28. Stinson K, Tang NKY, Harvey AG. Barriers to treatment seeking in primary insomnia in the United Kingdom: a cross-sectional perspective. Sleep. 2006;29(12):1643–6.

    Article  PubMed  Google Scholar 

  29. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307.

    Article  PubMed  Google Scholar 

  30. Morin CM, Vallières A, Ivers H. Dysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16). Sleep. 2007;30(11):1547–54.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ng F, Trauer T, Dodd S, Callaly T, Campbell S, Berk M. The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure. Acta Neuropsychiatr. 2007;19(5):304–10.

    Article  PubMed  Google Scholar 

  32. Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31(11):1601–7.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Vermeulen B, Goos P, Vandebroek M. Rank-order choice-based conjoint experiments: efficiency and design. J Stat Plan Inference. 2011;141(8):2519–31.

    Article  Google Scholar 

  34. Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making. Pharmacoeconomics. 2008;26(8):661–77.

    Article  PubMed  Google Scholar 

  35. Lusk JL. Effects of cheap talk on consumer willingness-to-pay for golden rice. Am J Agric Econ. 2003;85(4):840–56.

    Article  Google Scholar 

  36. Obse A, Ryan M, Heidenreich S, Normand C, Hailemariam D. Eliciting preferences for social health insurance in Ethiopia: a discrete choice experiment. Health Policy Plan. 2016;31(10):1423–32.

    Article  PubMed  Google Scholar 

  37. Bliemer MCJ, Rose JM. Confidence intervals of willingness-to-pay for random coefficient logit models. Trans Res Part B Methodol. 2013;58:199–214.

    Article  Google Scholar 

  38. Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13:173.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Falloon K, Elley CR, Fernando A 3rd, Lee AC, Arroll B. Simplified sleep restriction for insomnia in general practice: a randomised controlled trial. Br J Gen Pract. 2015;65(637):e508–15.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ellis JG, Cushing T, Germain A. Treating acute insomnia: a randomized controlled trial of a “single-shot” of cognitive behavioral therapy for insomnia. Sleep. 2014;38(6):971–8.

    Google Scholar 

  41. Ellis JG, Barclay NL. Cognitive Behavior Therapy for Insomnia: state of the science or a stated science? Sleep Med. 2014;15(8):849–50.

    Article  PubMed  Google Scholar 

  42. Dollman W, LeBlanc VT, Roughead E. Managing insomnia in the elderly: what prevents us using non-drug options? J Clin Pharm Ther. 2003;28(6):485–91.

    Article  CAS  PubMed  Google Scholar 

  43. Thomas A, Grandner M, Nowakowski S, Nesom G, Corbitt C, Perlis ML. Where are the behavioral sleep medicine providers and where are they needed? A geographic assessment. Behav Sleep Med. 2016;14(6):687–98.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Okada EM, Hoch SJ. Spending time versus spending money. J Consum Res. 2004;31(2):313–23.

    Article  Google Scholar 

  45. Everitt H, McDermott L, Leydon G, Yules H, Baldwin D, Little P. GPs’ management strategies for patients with insomnia: a survey and qualitative interview study. Br J Gen Pract. 2014;64(619):e112–9.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Cheung JMY, Atternäs K, Melchior M, Marshall NS, Fois RA, Saini B. Primary health care practitioner perspectives on the management of insomnia: a pilot study. Aust J Prim Health. 2013;20(1):103–12.

    Article  Google Scholar 

  47. Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report. Sleep. 2006;29(11):1415–9.

    Article  PubMed  Google Scholar 

  48. Pieterse AH, de Vries M, Kunneman M, Stiggelbout AM, Feldman-Stewart D. Theory-informed design of values clarification methods: a cognitive psychological perspective on patient health-related decision making. Soc Sci Med. 2013;77:156–63.

    Article  PubMed  Google Scholar 

  49. Alessi C, Vitiello MV. Insomnia (primary) in older people. BMJ Clin Evid. 2011;2011:2302.

    PubMed  PubMed Central  Google Scholar 

  50. Buysse DJ, Germain A, Moul DE, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med. 2011;171(10):887–95.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Ensor T, Cooper S. Overcoming barriers to health service access: influencing the demand side. Health Policy Plan. 2004;19(2):69–79.

    Article  PubMed  Google Scholar 

  52. Aikens JE, Rouse ME. Help-seeking for insomnia among adult patients in primary care. J Am Board Fam Pract. 2005;18(4):257–61.

    Article  PubMed  Google Scholar 

  53. Chen JA, Keller SM, Zoellner LA, Feeny NC. “How will it help me?” Reasons underlying treatment preferences between sertraline and prolonged exposure in PTSD. J Nerv Ment Dis. 2013;201(8):691–7.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Savage SJ, Waldman DM. Learning and fatigue during choice experiments: a comparison of online and mail survey modes. J Appl Econometr. 2008;23(3):351–71.

    Article  Google Scholar 

  55. Van de Mortel TF. Faking it: social desirability response bias in self-report research. Aust J Adv Nurs. 2008;25(4):40.

    Google Scholar 

  56. Fifer S, Rose J, Greaves S. Hypothetical bias in stated choice experiments: is it a problem? And if so, how do we deal with it? Transp Res Part A Policy Pract. 2014;61:164–77.

    Article  Google Scholar 

Download references

Acknowledgements

The current study was undertaken with financial support in the form of ‘seed funding’ provided by the National Health and Medical Research Council, CIRUS, Centre for Integrated Research and Understanding of Sleep, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia (grant number 571421). Bandana Saini is the chief investigator and Janet M. Y. Cheung is the associate investigator.

Author information

Authors and Affiliations

Authors

Contributions

JC conducted the research, analysis and writing of the initial draft of the manuscript. TL and JC conceptualized the initial econometric design for the research instrument. TL, JC BS, DB, CA refined the econometric design for the research instrument. TL provided expert advice on the econometric modelling technique and guided the data analysis. JC carried out the initial analysis and interpretation of the data. TL, DB, CA and BS provided advice on the interpretation of the data. All authors critically revised the manuscript.

Corresponding author

Correspondence to Janet M. Y. Cheung.

Ethics declarations

Conflict of interest

Janet M.Y. Cheung, Delwyn J. Bartlett, Carol L. Armour, Bandana Saini and Tracey-Lea Laba have no further financial or intellectual conflicts of interest to declare.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheung, J.M.Y., Bartlett, D.J., Armour, C.L. et al. Patient Preferences for Managing Insomnia: A Discrete Choice Experiment. Patient 11, 503–514 (2018). https://doi.org/10.1007/s40271-018-0303-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40271-018-0303-y

Navigation